A new regulator of B cell development

The researchers detected IL-33 during early B cell development in humans and found reduced IL-33 expression in B cell chronic lymphocytic leukemia samples compared to healthy controls.

Colorectal cancer researchers receive SPORE funding

Colorectal cancer researchers from Vanderbilt-Ingram Cancer Center (VICC) have been awarded a Specialized Program of Research Excellence grant from the National Cancer Institute (NCI).

Four Vanderbilt Technologies Earn Patent Protection in August

There have been 12 U.S. Patents issued in FY20. Here are the U.S. Patents issued in August: